Albert Bourla's banner

Albert Bourla

@AlbertBourla • 4,524,790 subscribers

Chairman and CEO of @Pfizer. Father. Optimist. Working every day for breakthroughs that change patients’ lives. 🇬🇷🇺🇸

Shorts

Today marks a significant moment for Pfizer Inc. with the completion of our acquisition of Liate COHEN. Their highly differentiated candidates for obesity and cardiometabolic disease combined with Pfizer as a powerhouse in primary care, commercialization and manufacturing position us to reshape the treatment landscape. We’re not just participating in the obesity category. We aim to define it. Look forward to welcoming our new expert colleagues.

Today marks a significant moment for Pfizer Inc. with the completion of our acquisition of Liate COHEN. Their highly differentiated candidates for obesity and cardiometabolic disease combined with Pfizer as a powerhouse in primary care, commercialization and manufacturing position us to reshape the treatment landscape. We’re not just participating in the obesity category. We aim to define it. Look forward to welcoming our new expert colleagues.

18,652 Aufrufe

Great news from our team to start the week: positive Phase 2 results for a potential first-in-class medicine discovered and developed entirely in-house at Pfizer Inc.. It has the potential to work differently from anything available today, targeting three drivers of inflammation in a single treatment. This could make a real difference for millions of people living with conditions like atopic dermatitis, COPD, and asthma. We're accelerating toward Phase 3 and excited about what lies ahead. This is the kind of innovation our pipeline is built to deliver. More:

Great news from our team to start the week: positive Phase 2 results for a potential first-in-class medicine discovered and developed entirely in-house at Pfizer Inc.. It has the potential to work differently from anything available today, targeting three drivers of inflammation in a single treatment. This could make a real difference for millions of people living with conditions like atopic dermatitis, COPD, and asthma. We're accelerating toward Phase 3 and excited about what lies ahead. This is the kind of innovation our pipeline is built to deliver. More:

11,404 Aufrufe

Videos

Anya Rossi

sweetdream.ai

SweetDream.ai•Sponsored•Livecam

Watch Anya Live

Anya is streaming live right now! Join her private show and enjoy exclusive content.

Exclusive private shows

1.2k viewers online

Private Show

Join now for exclusive access

Free preview available • Premium content

Our second quarter results are out today, and I am proud to report another strong quarter of execution. Thank you to my Pfizer Inc. colleagues, all of you, for everything behind these results and for your commitment to our purpose: breakthroughs that change patients’ lives.

Our second quarter results are out today, and I am proud to report another strong quarter of execution. Thank you to my Pfizer Inc. colleagues, all of you, for everything behind these results and for your commitment to our purpose: breakthroughs that change patients’ lives.

496,267 Aufrufe • vor 1 Monat

Another strong milestone for people living with MIBC. Our science continues to deliver more targeted options for patients who have been underserved for too long. Grateful to our teams and our partners at Astellas Pharma and Merck.

Another strong milestone for people living with MIBC. Our science continues to deliver more targeted options for patients who have been underserved for too long. Grateful to our teams and our partners at Astellas Pharma and Merck.

70,126 Aufrufe • vor 2 Monaten

Watching this ad filled me with pride and optimism about cancer breakthroughs—I’m grateful to have watched it with family, and glad they got my reaction when I made us watch it again!

Watching this ad filled me with pride and optimism about cancer breakthroughs—I’m grateful to have watched it with family, and glad they got my reaction when I made us watch it again!

53,878 Aufrufe • vor 1 Jahr

Pfizer started 2026 with focus and speed. Our first quarter results reflect what this team can deliver when we are aligned on what matters: strong commercial performance, meaningful pipeline progress, AI accelerating how we work across the organization and more. Every day we move faster is a day a patient gets an answer sooner. I am grateful to my colleagues for the remarkable work behind these results, and for remaining clear-eyed about our purpose.

Pfizer started 2026 with focus and speed. Our first quarter results reflect what this team can deliver when we are aligned on what matters: strong commercial performance, meaningful pipeline progress, AI accelerating how we work across the organization and more. Every day we move faster is a day a patient gets an answer sooner. I am grateful to my colleagues for the remarkable work behind these results, and for remaining clear-eyed about our purpose.

11,045 Aufrufe • vor 4 Monaten

Today marks a significant moment for Pfizer Inc. with the completion of our acquisition of Liate COHEN. Their highly differentiated candidates for obesity and cardiometabolic disease combined with Pfizer as a powerhouse in primary care, commercialization and manufacturing position us to reshape the treatment landscape. We’re not just participating in the obesity category. We aim to define it. Look forward to welcoming our new expert colleagues.

Today marks a significant moment for Pfizer Inc. with the completion of our acquisition of Liate COHEN. Their highly differentiated candidates for obesity and cardiometabolic disease combined with Pfizer as a powerhouse in primary care, commercialization and manufacturing position us to reshape the treatment landscape. We’re not just participating in the obesity category. We aim to define it. Look forward to welcoming our new expert colleagues.

18,652 Aufrufe • vor 9 Monaten

Today we’re stepping up the fight against cancer – entering into an agreement under which Pfizer Inc. will acquire @SeagenGlobal, a pioneer in antibody-drug conjugate technology, which is rapidly emerging as a powerful tool in cancer treatment:

Today we’re stepping up the fight against cancer – entering into an agreement under which Pfizer Inc. will acquire @SeagenGlobal, a pioneer in antibody-drug conjugate technology, which is rapidly emerging as a powerful tool in cancer treatment:

45,399 Aufrufe • vor 3 Jahren

Keine weiteren Inhalte verfügbar